dc.creatorBracalente, María Candelaria
dc.creatorSalguero, Noelia
dc.creatorNotcovich, Cintia Karina
dc.creatorMuller, Carolina
dc.creatorDa Motta, Leonardo L.
dc.creatorKlamt, Fabio
dc.creatorIbañez, Irene Laura
dc.creatorDuran, Hebe Alicia
dc.date.accessioned2020-05-29T20:38:28Z
dc.date.accessioned2022-10-15T06:11:44Z
dc.date.available2020-05-29T20:38:28Z
dc.date.available2022-10-15T06:11:44Z
dc.date.created2020-05-29T20:38:28Z
dc.date.issued2016-05
dc.identifierBracalente, María Candelaria; Salguero, Noelia; Notcovich, Cintia Karina; Muller, Carolina; Da Motta, Leonardo L.; et al.; Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Reversion or promotion of malignancy by inducing melanogenesis or metastasis; Impact Journals; Oncotarget; 7; 27; 5-2016; 41142-41153
dc.identifier1949-2553
dc.identifierhttp://hdl.handle.net/11336/106297
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4353786
dc.description.abstractAdvanced melanoma is the most aggressive form of skin cancer. It is highlymetastatic and dysfunctional in melanogenesis; two processes that are induced byH2O2. This work presents a melanoma cell model with low levels of H2O2 inducedby catalase overexpression to study differentiation/dedifferentiation processes.Three clones (A7, C10 and G10) of human A375 amelanotic melanoma cells withquite distinct phenotypes were obtained. These clones faced H2O2 scavenging by two main strategies. One developed by clone G10 where ROS increased. This resulted in G10 migration and metastasis associated with the increased of cofilin-1 and CAP1. The other strategy was observed in clone A7 and C10, where ROS levels were maintained reversing malignant features. Particularly, C10 was not tumorigenic, while A7 reversed the amelanotic phenotype by increasing melanin content and melanocytic differentiation markers. These clones allowed the study of potential differentiation and migration markers and its association with ROS levels in vitro and in vivo, providing a new melanoma model with different degree of malignancy.
dc.languageeng
dc.publisherImpact Journals
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=9220&path%5B%5D=28338
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.18632/oncotarget.9220
dc.rightshttps://creativecommons.org/licenses/by/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMELANOMA
dc.subjectCATALASE
dc.subjectROS
dc.subjectMELANOGENESIS
dc.subjectMETASTASIS
dc.titleReprogramming human A375 amelanotic melanoma cells by catalase overexpression: Reversion or promotion of malignancy by inducing melanogenesis or metastasis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución